The effect of combinations of flurbiprofen, low molecular weight heparin, and doxycycline on the inhibition of corneal neovascularization

Cornea

Volumn 25, Issue 5, 2006, Pages 582-585

  Peyman, Gholam A ^a   Kazi, Abdul Ahad ^a   Riazi Esfahani, Mohammad ^a   Aydin, Erdinc ^a   Kivilcim, Muhamet ^a   Sanders, Donald R ^b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Angiogenesis; Cornea; Doxycycline; Flurbiprofen; Low molecular weight heparinneovascularization

Indexed keywords

DOXYCYCLINE; ENOXAPARIN; FLURBIPROFEN; LOW MOLECULAR WEIGHT HEPARIN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUTERIZATION; CONTROLLED STUDY; CORNEA NEOVASCULARIZATION; DRUG EFFECT; ENUCLEATION; HISTOPATHOLOGY; NONHUMAN; PHOTOGRAPHY; PRIORITY JOURNAL; RAT; SLIT LAMP; TREATMENT OUTCOME; ANIMAL; CORNEA; DISEASE MODEL; DRUG COMBINATION; LONG EVANS RAT; PATHOLOGY; TOPICAL DRUG ADMINISTRATION; VASCULARIZATION;

ADMINISTRATION, TOPICAL; ANIMALS; CORNEA; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; DOXYCYCLINE; DRUG THERAPY, COMBINATION; FLURBIPROFEN; HEPARIN, LOW-MOLECULAR-WEIGHT; RATS; RATS, LONG-EVANS;

EID: 33746663718     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ico.0000220767.73660.3a     Document Type: Article

References (17)

1. Colby KA, Adamis AP. Prevalence of corneal neovascularization in a general eye service population. Invest Ophthalmol Vis Sci. 1996;37(suppl):S593 [abstract].
2. Chang JH, Gabison EE, Kato T, et al. Corneal neovascularization. Curr Opin Ophthalmol. 2001;12:242-249.
3. Mahoney JM, Waterbury LD. Drug effects on the neovascularization response to silver nitrate cauterization of the rat cornea. Curr Eye Res. 1985;4:531-535.
4. Folkman J, Shing Y. Angiogenesis. J Biol Chem. 1992;267:10931-10934.
5. Ashton N, Cook C, Langham M. Effect of cortisone on vascularization and opacification of the cornea induced by alloxan. Br J Ophthalmol. 1951;35:718-724.
6. Schwartz B. Corticosteroids and the eye. Int Ophthalmol Clin. 1966;6:753-1104.
7. Nikolic L, Friend J, Taylor S, et al. Inhibition of vascularization in rabbit corneas by herapin. Cortisone pellets. Invest Ophthalmol Vis Sci. 1986;27:449-456.
8. Phillips K, Arffa R, Cintron C, et al. Effects of prednisolone and medroxyprogesterone on corneal wound healing, ulceration, and neovascularization. Arch Ophthalmol. 1983;101:640-643.
9. BenEzra D, Griffin BW, Maftzir G, et al. Topical formulations of novel angiostatic steroids inhibit rabbit corneal neovascularization. Invest Ophthalmol Vis Sci. 1997;38:1954-1962.
10. Carnahan MC, Goldstein DA. Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol. 2000;11:478-483.
11. BenEzra DB. Neovasculogenesis. Triggering factors and possible mechanisms. Surv Ophthalmol. 1979;24:167-176.
12. Smorenburg SM, Van Noorden CJF. The complex effects of heparins on cancer progression and metastasis in experimental studies. Pharmacol Rev. 2001;53:93-105.
13. Lepri A, Benelli U, Bernardini N, et al. Effect of low molecular weight heparan sulphate on angiogenesis in the rat cornea after chemical cauterization. J Ocul Pharmacol. 1994;10:273-280.
14. Vlodavsky I, Ishai-Michaeli R, Mohsen M, et al. Modulation of neovascularization and metastasis by species of heparin. Adv Exp Med Biol. 1992;313:317-327.
15. Jayson GC, Gallagher JT. Heparin oligosaccharides. Inhibitors of the biological activity of bFGF on Caco-2 cells. Br J Cancer. 1997;75:9-16.
16. Golub LM, Ramamurthy NS, McNamara TF, et al. Tetracyclines inhibit connective tissue breakdown. New therapeutic implications for an old family of drugs. Crit Rev Oral Biol Med. 1991;2:297-321.
17. Hanemaaijer R, Visser H, Koolwijk P, et al. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res. 1998;12:114-118.